123 related articles for article (PubMed ID: 29660611)
1. Effect of in vivo exposure to ambient fine particles (PM
Andrade-Oliva MD; Aztatzi-Aguilar OG; García-Sierra F; De Vizcaya-Ruiz A; Arias-Montaño JA
Environ Toxicol Pharmacol; 2018 Jun; 60():58-65. PubMed ID: 29660611
[TBL] [Abstract][Full Text] [Related]
2. In vitro exposure to ambient fine and ultrafine particles alters dopamine uptake and release, and D
Andrade-Oliva MD; Escamilla-Sánchez J; Debray-García Y; Morales-Rubio RA; González-Pantoja R; Uribe-Ramírez M; Amador-Muñoz O; Díaz-Godoy RV; De Vizcaya-Ruiz A; Arias-Montaño JA
Environ Toxicol Pharmacol; 2020 Nov; 80():103484. PubMed ID: 32942001
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of dopamine-stimulated [35S]-guanosine 5'(gamma-thiotriphosphate) ([35S]GTPgammaS) binding in rat striatal membranes.
Rinken A; Finnman UB; Fuxe K
Biochem Pharmacol; 1999 Jan; 57(2):155-62. PubMed ID: 9890563
[TBL] [Abstract][Full Text] [Related]
4. Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5'-O-(gamma-thiotriphosphate) binding in rat striatal membranes.
Odagaki Y; Toyoshima R
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1304-12. PubMed ID: 16824659
[TBL] [Abstract][Full Text] [Related]
5. Effect of subchronic exposure to ambient fine and ultrafine particles on rat motor activity and
Andrade-Oliva MD; Debray-García Y; Morales-Figueroa GE; Escamilla-Sánchez J; Amador-Muñoz O; Díaz-Godoy RV; Kleinman M; Florán B; Arias-Montaño JA; De Vizcaya-Ruiz A
Inhal Toxicol; 2023; 35(1-2):1-13. PubMed ID: 36325922
[TBL] [Abstract][Full Text] [Related]
6. Enhanced striatal dopamine D(2) receptor-induced [35S]GTPgammaS binding after haloperidol treatment.
Geurts M; Hermans E; Maloteaux JM
Eur J Pharmacol; 1999 Oct; 382(2):119-27. PubMed ID: 10528146
[TBL] [Abstract][Full Text] [Related]
7. D2 receptor overexpression in the striatum leads to a deficit in inhibitory transmission and dopamine sensitivity in mouse prefrontal cortex.
Li YC; Kellendonk C; Simpson EH; Kandel ER; Gao WJ
Proc Natl Acad Sci U S A; 2011 Jul; 108(29):12107-12. PubMed ID: 21730148
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology of quinpirole-stimulated [35S]GTPgammaS binding: discrepancy with receptor binding profile.
Gilliland SL; Alper RH; Levant B
Eur J Pharmacol; 2000 Mar; 392(3):125-8. PubMed ID: 10762663
[TBL] [Abstract][Full Text] [Related]
9. Dopamine D2 receptor-mediated G-protein activation in rat striatum: functional autoradiography and influence of unilateral 6-hydroxydopamine lesions of the substantia nigra.
Newman-Tancredi A; Cussac D; Brocco M; Rivet JM; Chaput C; Touzard M; Pasteau V; Millan MJ
Brain Res; 2001 Nov; 920(1-2):41-54. PubMed ID: 11716810
[TBL] [Abstract][Full Text] [Related]
10. Autoradiographic analysis of dopamine receptor-stimulated [(35)S]GTPgammaS binding in rat striatum.
He L; Di Monte DA; Langston JW; Quik M
Brain Res; 2000 Dec; 885(1):133-6. PubMed ID: 11121540
[TBL] [Abstract][Full Text] [Related]
11. Alterations in the striatal dopamine system during intravenous methamphetamine exposure: effects of contingent and noncontingent administration.
Laćan G; Hadamitzky M; Kuczenski R; Melega WP
Synapse; 2013 Aug; 67(8):476-88. PubMed ID: 23417852
[TBL] [Abstract][Full Text] [Related]
12. Dopamine-induced functional activation of Gα
Odagaki Y; Kinoshita M; Ota T
J Recept Signal Transduct Res; 2019 Feb; 39(1):9-17. PubMed ID: 31223051
[TBL] [Abstract][Full Text] [Related]
13. Histamine H3 and dopamine D2 receptor-mediated [35S]GTPgamma[S] binding in rat striatum: evidence for additive effects but lack of interactions.
Humbert-Claude M; Morisset S; Gbahou F; Arrang JM
Biochem Pharmacol; 2007 Apr; 73(8):1172-81. PubMed ID: 17306767
[TBL] [Abstract][Full Text] [Related]
14. Subchronic haloperidol increases CB(1) receptor binding and G protein coupling in discrete regions of the basal ganglia.
Andersson M; Terasmaa A; Fuxe K; Strömberg I
J Neurosci Res; 2005 Oct; 82(2):264-72. PubMed ID: 16175569
[TBL] [Abstract][Full Text] [Related]
15. Signal transduction pathway activity compensates dopamine D₂/D₃ receptor density changes in Parkinson's disease: a preliminary comparative human brain receptor autoradiography study with [³H]raclopride and [³⁵S]GTPγS.
Farkas S; Nagy K; Jia Z; Hortobágyi T; Varrone A; Halldin C; Csiba L; Gulyás B
Brain Res; 2012 May; 1453():56-63. PubMed ID: 22480734
[TBL] [Abstract][Full Text] [Related]
16. Characterization of dopamine D
Egusquiza I; Munarriz-Cuezva E; Segarra R; González-Maeso J; Callado LF; Meana JJ; Diez-Alarcia R
Pharmacol Rep; 2021 Aug; 73(4):1136-1146. PubMed ID: 34196951
[TBL] [Abstract][Full Text] [Related]
17. Amphetamine-induced locomotion, behavioral sensitization to amphetamine, and striatal D2 receptor function in rats with high or low spontaneous exploratory activity: differences in the role of locus coeruleus.
Alttoa A; Eller M; Herm L; Rinken A; Harro J
Brain Res; 2007 Feb; 1131(1):138-48. PubMed ID: 17156751
[TBL] [Abstract][Full Text] [Related]
18. Dopamine-opioid interactions in the rat striatum: a modulatory role for dopamine D1 receptors in delta opioid receptor-mediated signal transduction.
Unterwald EM; Cuntapay M
Neuropharmacology; 2000 Jan; 39(3):372-81. PubMed ID: 10698003
[TBL] [Abstract][Full Text] [Related]
19. Serotonin 5-HT(1B/1D) agonist-stimulated [(35)S]GTPgammaS binding in rat and guinea pig striatal membranes.
Mize AL; Alper RH
Brain Res; 1999 Jul; 836(1-2):229-36. PubMed ID: 10415426
[TBL] [Abstract][Full Text] [Related]
20. Autoradiographic mapping of dopamine-D2/D3 receptor stimulated [35S]GTPgammaS binding in the human brain.
Sóvágó J; Makkai B; Gulyás B; Hall H
Eur J Neurosci; 2005 Jul; 22(1):65-71. PubMed ID: 16029196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
